Nasopharyngeal Carcinoma
📧 Sign up to get email alerts when something new happens for Nasopharyngeal Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-05-09Clinical Trial Update: Bintrafusp Alfa in Previously Treated Patients With R/M Non-keratinizing NPC [Phase 2]
A Phase 2 study of bintrafusp alfa in previously treated patients with recurrent/metastatic nasopharyngeal carcinoma (non-keratinizing histo…
-
CLINICAL_TRIALS trial_result · 2024-05-08Clinical Trial Update: A Phase 1 Study of BRG01 in Subjects With Relapsed/Metastatic Epstein-Barr Virus (EBV)-Positive Nasopharyngeal Carcinoma [Phase 1]
A Phase 1 study evaluating BRG01 in subjects with EBV-positive nasopharyngeal carcinoma has completed its Phase 1 portion.
-
CLINICAL_TRIALS trial_result · 2024-05-06Clinical Trial Update: Radiation Plus Concurrent Nimotuzumab in Elderly Patients With Locoregionally Advanced Nasopharyngeal Carcinoma [Phase 2]
Phase 2 trial evaluating radiation with nimotuzumab in elderly patients with locoregionally advanced nasopharyngeal carcinoma has completed.
-
CLINICAL_TRIALS research · 2024-05-02Clinical Trial Update: KSD-101 Therapy for Standard Treatment Failed EBV-associated NPC: an Exploratory Clinical Trial [EARLY_Phase 1]
An early-phase exploratory clinical trial evaluating KSD-101 therapy for EBV-associated nasopharyngeal carcinoma after standard treatment fa…
-
CLINICAL_TRIALS research · 2024-05-01Clinical Trial Update: Adding PD-1 Inhibitor to Neoadjuvant and Adjuvant for NPC [Phase 3]
Phase 3 trial update noting the addition of a PD-1 inhibitor to neoadjuvant and adjuvant therapy for Nasopharyngeal Carcinoma.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-05-01Clinical Trial Update: Xerostomia-optimised IMRT Versus Standard IMRT in NPC [NA]
A clinical trial comparing xerostomia-optimised IMRT versus standard IMRT for nasopharyngeal carcinoma to reduce dry mouth during radiothera…
-
CLINICAL_TRIALS research · 2024-04-30Clinical Trial Update: Maintenance Therapy With Toripalimab and Capecitabine Versus Capecitabine Alone in High-risk Nasopharyngeal Carcinoma [Phase 3]
This entry describes an ongoing Phase 3 clinical trial comparing maintenance therapy with toripalimab plus capecitabine versus capecitabine …
-
CLINICAL_TRIALS research · 2024-04-30Clinical Trial Update: Predictive Study on Acute Radiation Induced Oral Mucositis in Nasopharyngeal Carcinoma Patients
A predictive study evaluating acute radiation-induced oral mucositis in nasopharyngeal carcinoma patients is currently recruiting.
-
CLINICAL_TRIALS other · 2024-04-30Clinical Trial Update: Consolidative Radiotherapy Combined With Camrelizumab and Chemotherapy for Oligometastatic Nasopharyngeal Carcinoma [Phase 2]
Phase 2 trial evaluating consolidative radiotherapy with camrelizumab and chemotherapy for oligometastatic nasopharyngeal carcinoma; the stu…
-
CLINICAL_TRIALS research · 2024-04-25Clinical Trial Update: A Clinical Study of Anti-CD70 UCAR-T in Relapsed or Refractory Solid Tumors [Phase 1]
This is a Phase 1 clinical trial studying Anti-CD70 UCAR-T for relapsed or refractory solid tumors, with not yet recruiting status.
-
CLINICAL_TRIALS trial_result · 2024-04-18Clinical Trial Update: Neoadjuvant and Adjuvant Tislelizumab for Nasopharyngeal Carcinoma [Phase 3]
Phase 3 trial update evaluating neoadjuvant and adjuvant tislelizumab in nasopharyngeal carcinoma is active/not recruiting.
-
CLINICAL_TRIALS trial_result · 2024-04-09Clinical Trial Update: PD-1 Antibody Versus Best Supportive Care After Chemoradiation in Locoregionally Advanced Nasopharyngeal Carcinoma [Phase 3]
A Phase 3 trial compares a PD-1 antibody to best supportive care following chemoradiation in locoregionally advanced nasopharyngeal carcinom…
-
CLINICAL_TRIALS trial_result · 2024-03-15Clinical Trial Update: SHR-1210 in Recurrent/Metastatic Nasopharyngeal Carcinoma Who Have Received Previous At Least Two Lines of Chemotherapy. [Phase 2]
Phase 2 trial of SHR-1210 in recurrent/metastatic nasopharyngeal carcinoma after at least two prior lines of chemotherapy has completed with…
-
CLINICAL_TRIALS trial_result · 2024-03-06Clinical Trial Update: Camrelizumab and Chemotherapy Combined With Endoscopic Surgery for Recurrent Nasopharyngeal Carcinoma [Phase 2]
A Phase 2 clinical trial evaluating camrelizumab combined with chemotherapy and endoscopic surgery for recurrent nasopharyngeal carcinoma is…
-
CLINICAL_TRIALS trial_result · 2024-02-26Clinical Trial Update: A Head-to-head Comparison of [68Ga]Ga-FAPI and [68Ga]Ga-TATE PET/CT in Patients With Nasopharyngeal Carcinoma: a Single-center, Prospective Study [Phase 1, Phase 2]
A head-to-head prospective comparison of two PET/CT tracers for nasopharyngeal carcinoma has been completed in a single center, spanning Pha…
-
CLINICAL_TRIALS trial_result · 2024-02-08Clinical Trial Update: Bacterial Decolonization to Prevent Radiation-induced Oral Mucositis [Phase 3]
Phase 3 clinical trial evaluating bacterial decolonization to prevent radiation-induced oral mucositis in nasopharyngeal carcinoma patients …
-
CLINICAL_TRIALS trial_result · 2024-02-05Clinical Trial Update: A Multi-center, Randomized, Double-blind, Phase II/III Clinical Trial of AK104 or Placebo in Combination With Chemotherapy as Second-line or More Lines for Recurrent or Metastatic Nasopharyngeal Carcinoma (NPC) [Phase 2, Phase 3]
A multi-center randomized trial evaluating AK104 with chemotherapy vs placebo in second-line or later recurrent/metastatic nasopharyngeal ca…
-
CLINICAL_TRIALS trial_result · 2024-01-18Clinical Trial Update: Study of Docetaxel and Cisplatin Combined With Nimotuzumab As First-Line Treatment in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma [Phase 2]
Phase 2 trial evaluating docetaxel and cisplatin with nimotuzumab as first-line therapy for recurrent or metastatic nasopharyngeal carcinoma…
-
CLINICAL_TRIALS trial_result · 2023-12-15Clinical Trial Update: Reduced-dose RT With/Without CCT Versus Standard CCRT for High-risk LANPC Who Achieved CR Post Induction Chemotherapy [Phase 3]
A Phase 3 trial comparing reduced-dose radiotherapy with and without concurrent chemotherapy versus standard concurrent chemoradiation for h…
-
CLINICAL_TRIALS trial_result · 2023-12-05Clinical Trial Update: PD-1 Inhibitor Plus Anti-EGFR Therapy And Radiotherapy in Locally Advanced NPC Resistant to Induction Chemotherapy [Phase 2]
Phase 2 clinical trial evaluating PD-1 inhibitor with anti-EGFR therapy and radiotherapy for locally advanced nasopharyngeal carcinoma resis…
-
CLINICAL_TRIALS trial_result · 2023-11-22Clinical Trial Update: A Phase II/III Trial to Evaluate the Efficacy and Safety of QL1706 in Patients With Nasopharyngeal Carcinoma [Phase 2, Phase 3]
Phase II/III trial evaluating the efficacy and safety of QL1706 in patients with nasopharyngeal carcinoma; current status is unknown.
-
CLINICAL_TRIALS trial_result · 2023-10-25Clinical Trial Update: Anlotinib in Recurrent or Metastatic Nasopharyngeal Carcinoma Patients After Failure of no Less Than Second-line Therapy [Phase 2]
Phase 2 clinical trial evaluating anlotinib in recurrent or metastatic nasopharyngeal carcinoma after failure of at least second-line therap…
-
CLINICAL_TRIALS trial_result · 2023-10-23Clinical Trial Update: KL-A167 Injection in Recurrent or Metastatic Nasopharyngeal Carcinoma [Phase 2]
Phase 2 clinical trial update for KL-A167 injection in recurrent or metastatic nasopharyngeal carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2023-10-23Clinical Trial Update: Induction Chemotherapy and Immunotherapy Combined Radiotherapy With or Without Concurrent Chemotherapy for Stage III-IVa NPC [Phase 3]
Phase 3 trial evaluating induction chemotherapy and immunotherapy combined radiotherapy with or without concurrent chemotherapy for stage II…
-
CLINICAL_TRIALS trial_result · 2023-10-11Clinical Trial Update: Phase 2 Trial of Ipilimumab and Nivolumab in Nasopharyngeal Carcinoma [Phase 2]
Phase 2 trial evaluating ipilimumab and nivolumab in nasopharyngeal carcinoma is in progress with unknown status.